Document is current
Any future updates will be listed below
-
Authors
Yuan, Meng
Tian, Xiaoyan
Ma, Wenyuan
Zhang, Rui
Zou, Xue
Jin, Yu
Zheng, Nan
Wu, Zhiwei https://orcid.org/0000-0002-0672-948X
Wang, Yongxiang
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81672020, 82072423, 82272502, 31970149, U22A20335)
Nation Key Research and Development Program of China (2023YFB3810200)
Nation Key Research and Development Program of China (2023YFB3810204)
- License Information
-
More Information
Article History
Received: 2 June 2024
Accepted: 3 November 2024
First Online: 19 November 2024
Declarations
:
: All animal experimental protocols were approved by the Nanjing University Animal Care Committee and followed the ‘Guide for the Care and Use of Laboratory Animals’ published by the Chinese National Institutes of Health. And the approval number is No: IACUC-D2202180, the date of approval was January 2023. The research protocols were conducted in accordance with the animal behavioral guidelines, using approved protocols from the institutional animal care committee. For umbilical cord mesenchymal stem cells (HucMSCs) collection, the study entitled “Stem cells are extracted from clinical patient samples (tissues, blood, body fluids) and aborted fetal tissues for basic regenerative medicine and clinical disease treatment research” was approved by the Clinical Stem Cell Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School (Date: 11. 29. 2023, No.2017-161-08) and was conducted following approved institutional guidelines. Written informed consent was obtained from all donors prior to this study.
: The authors declare that they have no competing interests. The authors declare that artificial intelligence is not used in this study.
